INS and type 1 diabetes mellitus: The autoimmune workup revealed impaired endogenous insulin production, indicated by low C-peptide levels, a condition typical in type 1 diabetes (T1D) and insulin-dependent type 2 diabetes, and associated with poorer glycemic control outcomes [8].